Global Information
회사소개 | 문의 | 비교리스트

세계의 동물용 의약품 시장 예측(2019-2028년)

Global Veterinary Medicines Market Forecast 2019-2028

리서치사 Inkwood Research
발행일 2020년 10월 상품 코드 962720
페이지 정보 영문 219 Pages
가격
US $ 2,500 ₩ 2,866,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,439,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,159,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 동물용 의약품 시장 예측(2019-2028년) Global Veterinary Medicines Market Forecast 2019-2028
발행일 : 2020년 10월 페이지 정보 : 영문 219 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 동물용 의약품 시장 규모는 2019-2028년의 예측기간 중 4.53%의 CAGR이 전망됩니다. 가축수 증가, 의료비 상승, 애완동물 소유 확대 및 질병 유병률 증가는 시장 성장에 영향을 미칠 것으로 예측됩니다.

동물은 즉시 치료와 주의를 필요로 하는 다양한 병상을 경험합니다. 이러한 치료에 사용되는 백신, 약용 사료첨가물 및 약물은 동물용 의약품으로 불립니다. 이것들은 진균이나 박테리아의 성장을 방지 또는 늦춥니다. 동물과의 교류는 삶의 질을 높이는 것으로 알려져 있으며, 인간의 건강에 플러스 영향을 미칩니다. 세계에서 애완동물 소유가 크게 증가하고 있습니다. 또한 백신 접종이나 질병의 시기적절한 진단에 관한 동물의 건강에 대한 인식 확산은 세계의 동물용 의약품 수요 급증에 기여하고 있습니다. 동시에 동물과 인간의 건강에 대한 수의용 백신의 부작용, 기본적인 인프라 결여, 비용이 드는 예방 접종 및 엄격한 규제가 시장 성장을 저해하고 있습니다.

세계의 동물용 의약품(Veterinary Medicines) 시장에 대해 조사했으며, 시장 개요, 시장에 영향을 미치는 요인 분석, 각 부문·하위 부문·지역별 시장 예측 및 주요 기업 개요 등을 제공합니다.

목차

제1장 조사 범위 및 조사 방법

  • 조사 목적
  • 조사 범위
  • 조사 방법
  • 가정·제한

제2장 주요 요약

  • 시장 규모·추정
  • 시장 개요

제3장 시장 역학

  • 시장 정의
  • 주요 촉진요인
    • 가축수 급증
    • 동물 의료비 상승
    • 애완동물 소유 증가
    • 동물의 몇 가지 질병 유병률 상승
  • 주요 억제요인
    • 동물용 의약품에 관한 엄격한 규제
    • 동물용 백신과 관련된 사람 및 동물의 건강에 대한 부작용
    • 신흥 경제 국가의 축산을 위한 기본적인 인프라 시설 결여
    • 예방 접종의 고비용
    • 북미의 채식주의와 비거니즘 인기 상승

제4장 주요 분석

  • Porter's Five Forces 분석
  • 밸류체인 분석
  • 규제 체계
  • COVID-19가 동물용 의약품 시장에 미치는 영향
  • 기회 매트릭스
  • 벤더 상황
  • 주요 투자 인사이트

제5장 시장 : 동물 종류별

  • 반려동물
  • 가축동물

제6장 시장 : 유통 채널별

  • 소매 수의 약국
  • 수의 병원 약국

제7장 시장 : 투여 경로별

  • 비경구 경로
  • 경구 경로
  • 국소 경로

제8장 시장 : 제품별

  • 약물
    • 항감염제
    • 항염증제
    • 구충제
  • 백신
    • 불활화 백신
    • 약독화 백신
    • 재조합 백신
  • 약용 사료첨가물
    • 항생물질
    • 아미노산

제9장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아
    • 폴란드
    • 벨기에
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 호주·뉴질랜드
    • 인도
    • 한국
    • 태국
    • 인도네시아
    • 베트남
    • 기타 아시아태평양
  • 기타 지역
    • 라틴아메리카
    • 중동 및 아프리카

제10장 기업 개요

  • ARCHER DANIELS MIDLAND
  • BIOGENESIS BAGO SA
  • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • CEVA SANTE ANIMALE
  • DECHRA PHARMACEUTICALS PLC
  • ELANCO
  • EVONIK INDUSTRIES AG(RAG STIFTUNG)
  • HESTER BIOSCIENCES LIMITED
  • INDIAN IMMUNOLOGICALS LIMITED
  • KINDRED BIOSCIENCES
  • MERCK & CO
  • NEOGEN CORPORATION
  • VETOQUINOL(SOPARFIN SCA)
  • VIRBAC SA
  • ZOETIS
KSM 20.10.15

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - VETERINARY MEDICINES
  • TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)
  • TABLE 3: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL COMPANION ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL COMPANION ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL ORAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL ORAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL TOPICAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL TOPICAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL VACCINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL VACCINES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL VACCINES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 41: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 43: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 45: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019
  • FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 10: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019
  • FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD VETERINARY MEDICINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

KEY FINDINGS

The global veterinary medicines market is estimated to grow with a CAGR of 4.53% during the forecast period, 2019-2028. The increasing livestock population, rising healthcare expenditure, growing pet ownership, and rising prevalence of diseases, are projected to influence the growth of the market.

MARKET INSIGHTS

Animals undergo different medical conditions that require immediate treatment and attention. Vaccines, medicated feed additives, and drugs, used for such treatment are called veterinary medicines. These prevent or slow the growth of the fungi and bacteria. The company of animals is known to enhance the quality of life, and has a positive impact on human health. There has been a considerable rise in pet ownership across the globe. In 2018 alone, 1 in 80 million households owned a pet in Europe. Thus, such a huge population is fueling the demand for veterinary medicines. Also, the rising awareness of animal health with regard to vaccine regimes and timely diagnosis of diseases are contributing to the surge in demand for veterinary medicines across the world. At the same time, the side effects of veterinary vaccines on animal & human health, lack of basic infrastructure, costly vaccinations, and strict regulations, are set to hamper the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global veterinary medicines market includes the evaluation of Asia Pacific, Europe, North America, and the rest of the world. North America is set to dominate the global market throughout the forecast period. The increasing number of pet owners is one of the dominant factors contributing to the growth of the region.

COMPETITIVE INSIGHTS

The global veterinary medicines market is evaluated to be highly competitive over the forecast period. Some of the major players in the market include, Archer Daniels Midland, Biogenesis Bago SA, Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. SURGING LIVESTOCK POPULATION
    • 3.2.2. INCREASING ANIMAL HEALTHCARE EXPENDITURE
    • 3.2.3. GROWING PET OWNERSHIP
    • 3.2.4. RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
    • 3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
    • 3.3.3. LACK OF BASIC INFRASTRUCTURE FACILITIES FOR THE VETERINARY ANIMALS IN THE UNDERDEVELOPED ECONOMIES
    • 3.3.4. HIGH COST OF VACCINATIONS
    • 3.3.5. RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. VALUE CHAIN ANALYSIS
  • 4.3. REGULATORY FRAMEWORK
  • 4.4. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY ANIMAL TYPE

  • 5.1. COMPANION ANIMALS
  • 5.2. LIVESTOCK ANIMALS

6. MARKET BY DISTRIBUTION CHANNEL

  • 6.1. RETAIL VETERINARY PHARMACIES
  • 6.2. VETERINARY HOSPITAL PHARMACIES

7. MARKET BY ROUTE OF ADMINISTRATION

  • 7.1. PARENTERAL ROUTE
  • 7.2. ORAL ROUTE
  • 7.3. TOPICAL ROUTE

8. MARKET BY PRODUCT

  • 8.1. DRUGS
    • 8.1.1. ANTI-INFECTIVE
    • 8.1.2. ANTI-INFLAMMATORY
    • 8.1.3. PARASITICIDE
  • 8.2. VACCINES
    • 8.2.1. INACTIVATED VACCINES
    • 8.2.2. ATTENUATED VACCINES
    • 8.2.3. RECOMBINANT VACCINES
  • 8.3. MEDICATED FEED ADDITIVES
    • 8.3.1. ANTIBIOTICS
    • 8.3.2. AMINO ACIDS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. POLAND
    • 9.2.7. BELGIUM
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. AUSTRALIA & NEW ZEALAND
    • 9.3.4. INDIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. ARCHER DANIELS MIDLAND
  • 10.2. BIOGENESIS BAGO SA
  • 10.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • 10.4. CEVA SANTE ANIMALE
  • 10.5. DECHRA PHARMACEUTICALS PLC
  • 10.6. ELANCO
  • 10.7. EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • 10.8. HESTER BIOSCIENCES LIMITED
  • 10.9. INDIAN IMMUNOLOGICALS LIMITED
  • 10.10. KINDRED BIOSCIENCES
  • 10.11. MERCK & CO
  • 10.12. NEOGEN CORPORATION
  • 10.13. VETOQUINOL (SOPARFIN SCA)
  • 10.14. VIRBAC SA
  • 10.15. ZOETIS
Back to Top
전화 문의
F A Q